Ocugen (OCGN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov6

H.C. Wainwright Analyst Reiterates Buy Rating on Ocugen

11:32

Nov5

Ocugen released FY2025 Q3 earnings on November 5 Pre-Market EST, actual revenue USD 1.752 M (forecast USD 440 K), actual EPS USD -0.0699 (forecast USD -0.056)

14:30

Ocugen released FY2025 9 Months Earnings on November 5, Pre-Market EST, with actual revenue of USD 4.606 M and EPS of USD -0.1689

14:30

Ocugen Inc. Reports Clinical Trial Progress and Completes $20 Million Direct Offering

11:30

Oct29

Ocugen to Release FY2025 Q3 Earnings on November 5, Pre-Market EST; Forecast Revenue USD 440 K, EPS USD -0.056

00:47

Oct2

Ocugen Executives to Attend Multiple Conferences to Share Progress in Blindness Gene Therapy

11:31

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.752 M, Net Income -20.05 M, EPS -0.0659

Aug1

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.373 M, Net Income -14.74 M, EPS -0.0504

May9

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.481 M, Net Income -15.35 M, EPS -0.0525

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change